Scarica l'app Stockscreener
16.95
2.53%
-0.44
Precedente Chiudi:
$17.39
Aprire:
$17.56
Volume 24 ore:
644.25K
Relative Volume:
1.87
Capitalizzazione di mercato:
$579.90M
Reddito:
-
Utile/perdita netta:
$-81.05M
Rapporto P/E:
-6.4616
EPS:
-2.6232
Flusso di cassa netto:
$-68.97M
1 W Prestazione:
-12.85%
1M Prestazione:
-21.64%
6M Prestazione:
-36.99%
1 anno Prestazione:
-24.33%
Intervallo 1D:
$16.10
$17.68
Intervallo di 1 settimana:
$16.10
$19.36
Portata 52W:
$15.47
$36.37
Arrivent Biopharma Inc Stock (AVBP) Company Profile
Nome
Arrivent Biopharma Inc
Settore
Industria
Telefono
240-780-6356
Indirizzo
18 CAMPUS BLVD., NEWTOWN SQUARE
Confronta AVBP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVBP
Arrivent Biopharma Inc
|
16.95 | 638.13M | 0 | -81.05M | -68.97M | -2.6232 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Arrivent Biopharma Inc Stock (AVBP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-10 | Ripresa | Goldman | Buy |
| 2025-03-20 | Iniziato | B. Riley Securities | Buy |
| 2025-03-10 | Iniziato | Guggenheim | Buy |
| 2024-07-22 | Iniziato | Oppenheimer | Outperform |
| 2024-04-30 | Iniziato | H.C. Wainwright | Buy |
| 2024-02-20 | Iniziato | Citigroup | Buy |
| 2024-02-20 | Iniziato | Goldman | Buy |
| 2024-02-20 | Iniziato | Jefferies | Buy |
Mostra tutto
Arrivent Biopharma Inc Borsa (AVBP) Ultime notizie
ArriVent Biopharma price target raised to $42 from $40 at H.C. Wainwright - TipRanks
ArriVent Biopharma price target lowered to $33 from $40 at Citi - TipRanks
H.C. Wainwright raises ArriVent BioPharma stock price target to $42 on NSCLC drug potential - Investing.com Canada
Candlestick signals on ArriVent BioPharma Inc. stock todayFree Weekly Watchlist of High Movers - Newser
ArriVent BioPharma Inc. stock trend outlook and recovery pathFree Short Term High Yield Stock Tips - Newser
How to interpret RSI for ArriVent BioPharma Inc. stockPattern Breakout Prediction for Short Term - Newser
What makes ArriVent BioPharma Inc. stock price move sharplyFree Real Time Alerts Based on AI Prediction - Newser
Why ArriVent BioPharma Inc. stock attracts strong analyst attentionFree Low Capital High Return Stock Plans - Newser
Does ArriVent BioPharma Inc. qualify in momentum factor screeningSector Rotation Strategy for Smart Traders - Newser
Understanding ArriVent BioPharma Inc.’s price movementFree Breakout Entry Signal Confirmation Tool - Newser
ArriVent Biopharma reports Q2 EPS (90c), consensus (71c) - TipRanks
ArriVent Biopharma sees cash runway into mid-2027 - TipRanks
ArriVent Posts Wider Loss in Fiscal Q2 - The Motley Fool
ArriVent Posts Wider Loss in Fiscal Q2 - Nasdaq
ArriVent BioPharma, Inc. SEC 10-Q Report - TradingView
ArriVent BioPharma Reports Second Quarter 2025 Financial Results - Stock Titan
Custom strategy builders for tracking ArriVent BioPharma Inc.Free Triple Return Setup with Risk Control - Newser
ArriVent BioPharma (AVBP) Projected to Post Quarterly Earnings on Wednesday - Defense World
Predicting ArriVent BioPharma Inc. trend using moving averagesFree Consistent Profit Pattern Recognition Tools - Newser
ArriVent BioPharma Inc. recovery potential after sell offExit Strategy Guide With Risk Control Plan - Newser
How hedge fund analytics apply to ArriVent BioPharma Inc. stockEntry Confirmation Using Short-Term Forecasting - Newser
ArriVent BioPharma Inc. stock retracement – recovery analysisBuy Alert Based on RSI and Volume - Newser
Will ArriVent BioPharma Inc. price bounce be sustainableEntry Timing Tracker with Alert Accuracy - Newser
Does ArriVent BioPharma Inc. fit your quant trading modelSmart Stock Forecast Using AI Algorithms - Newser
News impact scoring models applied to ArriVent BioPharma Inc.Trade Flow Monitor with Volume Tracker - Newser
Lepu Biopharma Reports First-Ever Profit Amid Revenue Surge - TipRanks
ArriVent BioPharma Inc. Company’s Quarterly Earnings Growth: What the Numbers SayWeekly Return Plan for Conservative Traders - Newser
Thermo Fisher to lay off 85 workers in San Diego County; Lepu Biopharma inks a deal - Endpoints News
How many analysts rate ArriVent BioPharma Inc. as a “Buy”Capitalize on high-growth stocks early - Jammu Links News
What is ArriVent BioPharma Inc. company’s growth strategyGet exclusive market insights for better trading - Jammu Links News
ArriVent BioPharma Inc. Stock Analysis and ForecastTrack high-yield stocks before they peak - Jammu Links News
How strong is ArriVent BioPharma Inc. company’s balance sheetMaximize gains with proven stock analysis - Jammu Links News
What is the risk reward ratio of investing in ArriVent BioPharma Inc. stockTake advantage of unprecedented market momentum - Jammu Links News
Why is ArriVent BioPharma Inc. stock attracting strong analyst attentionStay ahead with advanced stock screening tools - Jammu Links News
How volatile is ArriVent BioPharma Inc. stock compared to the marketDynamic growth stocks - Jammu Links News
Is ArriVent BioPharma Inc. stock overvalued or undervaluedCapitalize on fast-growing stocks today - Jammu Links News
What are ArriVent BioPharma Inc. company’s key revenue driversUnlock powerful market insights for success - Jammu Links News
How does ArriVent BioPharma Inc. compare to its industry peersUnlock exclusive stock market forecasts - Jammu Links News
Does ArriVent BioPharma Inc. stock perform well during market downturnsSuperior trading gains - Jammu Links News
When is ArriVent BioPharma Inc. stock expected to show significant growthBuild a winning portfolio with smart picks - Jammu Links News
How does ArriVent BioPharma Inc. generate profit in a changing economyFree Stock Market Knowledge Sharing - Jammu Links News
ArriVent BioPharma Inc. stock prediction for this weekAI Generated Buy/Sell Signal Forecast - Newser
Can you recover from losses in ArriVent BioPharma Inc.Free Real Trader Watchlist of Hot Stocks - Newser
Can trapped investors hope for a rebound in ArriVent BioPharma Inc.Predictive Short-Term Market Reversal Alerts - Newser
Using data models to predict ArriVent BioPharma Inc. stock movementFree Fundamental + Technical Hybrid Stock Tips - Newser
Quant Tools Rank ArriVent BioPharma Inc. as High Risk High RewardTrend Analysis for Safer Trades Gains Popularity - metal.it
Comparing ArriVent BioPharma Inc. in custom built stock radarsSmart Chart Forecasting with AI Algorithms - Newser
ArriVent BioPharma Inc. stock trend forecastBuy Signal System Based on Price Action - Newser
ArriVent BioPharma Inc. Earnings Report Breakdown: What Investors Should KnowMachine Learning Intraday Signal Forecast - Newser
Arrivent Biopharma Inc Azioni (AVBP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.91%
3.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):